Post-ERCP pancreatitis: Is allopurinol the Holy Grail?

Gastrointestinal Endoscopy

Volumn 62, Issue 2, 2005, Pages 251-252

  Harewood, Gavin C ^a   Topazian, Mark ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL;

DIAGNOSTIC PROCEDURE; DRUG EFFICACY; EDITORIAL; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; MEDICAL INSTRUMENTATION; MEDICAL PRACTICE; PANCREAS DUCT; PANCREATITIS; PRIORITY JOURNAL; RISK ASSESSMENT;

ALLOPURINOL; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; FREE RADICAL SCAVENGERS; HUMANS; PANCREATITIS;

EID: 22544431687     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gie.2005.04.024     Document Type: Editorial

References (14)

1. S. Sherman, U. Blaut, J. Watkins, J. Barnett, M. Freeman, and J. Geenen Does the prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: a randomized, prospective, multicenter study Gastrointest Endosc 58 2003 23 29
2. A. Budzynska, T. Marek, A. Nowak, R. Kaczor, and E. Nowakowska-Dulawa A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis Endoscopy 33 2001 766 772
3. A. Andriulli, G. Leandro, G. Niro, A. Mangia, V. Festa, and G. Gambassi Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis Gastrointest Endosc 51 2000 1 7
4. G. Johnson, J. Geenen, R. Bedford, J. Johanson, O. Cass, and S. Sherman A comparison of nonionic versus ionic contras media: results of a prospective, multicenter study Gastrointest Endosc 42 1995 312 316
5. S. Sherman, C.L. Chen, G. Costamagna, K. Binmoeller, A. Puespoek, and G.P. Aithal Efficacy of recombinant human interleukin-10 in prevention of acute pancreatitis after ERCP in subjects at increased risk: randomized prospective multicenter study [abstract] Gastrointest Endosc 2005 61:AB99
6. S. Sherman, G. Lehman, J. Geenen, R. Chuttani, R. Kozarek, and J. Pribble Evaluation of recombinant human platelet activating factor acetylhydrolase (RPAF-AH) for reducing the incidence and severity of post-ERCP acute pancreatitis [abstract] Gastrointest Endosc 51 2000 AB67
7. M. Freeman, and N. Guda Prevention of post-ERCP pancreatitis: a comprehensive review Gastrointest Endosc 59 2004 845 864
8. H. Sanfey, G. Bulkley, and J. Cameron The pathogenesis of acute pancreatitis. The source and role of oxygen-derived free radicals in three different experimental models Ann Surg 201 1984 633 639
9. J. Mark, B. Dunkin, B. Shillingstad, D. Youngelman, M. Schweitzen, and R. Lash Pretreatment with allopurinol diminishes pancreatography-induced pancreatitis in a canine model Gastrointest Endosc 48 1998 180 183
10. P. Katsinelos, J. Kountouras, J. Chatzis, K. Christodoulou, G. Paroutoglou, and K. Mimidis High-dose allopurinol for prevention of post-ERCP pancreatitis: a prospective randomized double-blind controlled trial Gastrointest Endosc 61 2005 407 415
11. P. Mosler, S. Sherman, J. Marks, J.L. Watkins, J.E. Geenen, and P. Jamidar Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis Gastrointest Endosc 62 2005 245 250
12. P. Tarnasky, Y. Palesch, J. Cunningham, P. Mauldin, P. Cotton, and R. Hawes Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction Gastroenterology 115 1998 1518 1524
13. M. Moreto, M. Zaballa, I. Casado, O. Merino, M. Rueda, and K. Ramirez Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: a randomized double-blind trial Gastrointest Endosc 57 2003 1 7
14. B. Murray, R. Carter, C. Imrie, S. Evans, and C. O'Suilleabhain Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography Gastroenterology 124 2003 1786 1791